Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
116 Ergebnisse für "promise" unter Roche Glycart AG
The moment LCDs showed promise
... The moment LCDs showed promise When it comes to following the science, the journey is as important ... The moment LCDs showed promise ... The moment LCDs showed promise Science Culture Community Participate Go to roche.com Science ... The moment LCDs showed promise ...
The moment LCDs showed promise
... The moment LCDs showed promise When it comes to following the science, the journey is as important ... The moment LCDs showed promise ... The moment LCDs showed promise Science Culture Community Participate Go to roche.com Science ... The moment LCDs showed promise ...
CSL Vifor
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor
8952 Schlieren, Zürcherstrasse 39D
+41 58 851 80 00
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
CSL Vifor
Zürcherstrasse 39D
8952 Schlieren
154 Ergebnisse für "promise" unter CSL Vifor
Driven By Our Promise|CSL Overview
... Driven By Our Promise|CSL Overview ... Driven By Our Promise|CSL Overview Skip navigation CSL Logo The text 'CSL' in bold red all capitals ... Driven By Our Promise|CSL Overview ...
Biotech Podcast | CSL World of Promise Podcasts
... CSL Podcast: World of Promise Each episode features conversations with leading medical experts ... Chief Communications Officer, who is also the show’s host. World of Promise is available on Apple ... Biotech Podcast | CSL World of Promise Podcasts ... Biotech Podcast | CSL World of Promise Podcasts Skip to main content Global Selector Newsroom ... Biotech Podcast | CSL World of Promise Podcasts ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
252 Ergebnisse für "promise" unter Somagenetix
Premise and promise of mesenchymal stem cell-based therapies in cli...
... Schweizer, Riccardo ; Gorantla, Vijay S ; Plock, Jan A (2015). Premise and promise of mesenchymal ... Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite ... Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite ... Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite ...
The promise and the peril of using social influence to reverse harm...
... The promise and the peril of using social influence to reverse harmful traditions Efferson, Charles ... ; Vogt, Sonja ; Fehr, Ernst (2020). The promise and the peril of using social influence to reverse ... The promise and the peril of using social influence to reverse harmful traditions - Zurich Open ... The promise and the peril of using social influence to reverse harmful traditions - Zurich Open ... The promise and the peril of using social influence to reverse harmful traditions - Zurich Open ...
Neurimmune Therapeutics AG
8952 Schlieren, Wagistrasse 18
+41 44 755 46 46
info@neurimmune.com
Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.
Neurimmune Therapeutics AG
Wagistrasse 18
8952 Schlieren
53 Ergebnisse für "promise" unter Neurimmune Therapeutics AG
Neurimmune - 21.08.2013: Human-Derived SOD1 Antibodies Show Promise...
... Neurimmune - 21.08.2013: Human-Derived SOD1 Antibodies Show Promise in ALS Mice Company About ... Contact Neurimmune April 17, 2013 Human-Derived SOD1 Antibodies Show Promise in ALS Mice Read more ... Neurimmune - 21.08.2013: Human-Derived SOD1 Antibodies Show Promise in ALS Mice ... http://www.neurimmune.com/newsartikel/21082013-human-derived-sod1-antibodies-show- promise-in-als ... Neurimmune - 21.08.2013: Human-Derived SOD1 Antibodies Show Promise in ALS Mice ...
Neurimmune Holding AG | News and Press Releases
... Show Promise in ALS Mice 20.12.2010 Biogen Idec and Neurimmune announce agreement on three ... Show Promise in ALS Mice 20.12.2010 Biogen Idec and Neurimmune announce agreement on three ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
212 Ergebnisse für "promise" unter ETH Entrepreneurship
Flusser, Into the Universe of Technical Images – Xenotheka
... images carries both promise and threat: the promise of freeing humans to play and invent and the threat ... technical images carries both promise and threat: the promise of freeing humans to play and invent and the ...
MASQUERADE OF SECURITY – D-ARCH
... expressions of ideologies and power. But the mock up is also a promise and reminder that things don’t always ... mock up is also a promise and reminder that things don’t always have to be the way they are intended to ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
136 Ergebnisse für "promise" unter University of Zurich
Applying machine learning methods to avalanche forecasting - Zurich...
... a spatial forecast show promise, but require further work. Abstract Avalanche forecasting is a ... the ability of SVMs to deal with high dimensionality in producing a spatial forecast show promise, but ... show promise, but require further work. Abstract Avalanche forecasting is a complex process involving ... deal with high dimensionality in producing a spatial forecast show promise, but require further work ...
The impact of metalation on adsorption geometry, electronic level a...
... recently shown promise as water reduction catalysts in homogeneous photochemical water splitting reactions ... complexes of the tetradentate bipyridine based macrocycle pyrphyrin (Pyr) have recently shown promise as ... bipyridine based macrocycle pyrphyrin (Pyr) have recently shown promise as water reduction catalysts in ... macrocycle pyrphyrin (Pyr) have recently shown promise as water reduction catalysts in homogeneous ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
5 Ergebnisse für "promise" unter Bio-Technopark Schlieren-Zürich
Personalized Health Technologies Conference 2024 › BIO-TECHNOPARK® ...
... Disease Mechanisms From Shelf to Cure: The Promise of Drug Repurposing and in vitro Diagnostics The ... Disease Mechanisms From Shelf to Cure: The Promise of Drug Repurposing and in vitro Diagnostics The ...
Molecular Partners Receives Orphan Drug Designation for MP0250 for ...
... development of products that demonstrate promise for the diagnosis and/or treatment of rare diseases or ... Development (OOPD) is to advance the evaluation and development of products that demonstrate promise for the ...
ImmunOs Therapeutics AG
http://immunostherapeutics.com/
8952 Schlieren, Wagistrasse 14
ImmunOs Therapeutics AG is a clinical-stage biotechnology company developing the next generation of novel immunotherapies that enhance the efficacy of market leading checkpoint inhibitors and costimulatory agonists for cancer therapy. The company is actively discussing and exploring new strategic collaborations with leading global pharmaceutical companies.
ImmunOs Therapeutics AG
Wagistrasse 14
8952 Schlieren
1 Ergebnisse für "promise" unter ImmunOs Therapeutics AG
Background on Cancer Immunotherapy - Immunostherapy
... will make the tumor much more vulnerable to immunotherapy. This approach holds the promise of better ... approach holds the promise of better treatment outcomes and applicability to a larger patient population ...
PharmaBiome
8952 Schlieren, Wagistrasse 27
PharmaBiome has developed unique technologies to access the entire range of intestinal bacteria for the design and production of function-based consortia at scale.
PharmaBiome
Wagistrasse 27
8952 Schlieren
1 Ergebnisse für "promise" unter PharmaBiome
Microbiome derived therapies | PharmaBiome
... Collaborate Therapies Leading-edge therapies that leverage the microbiome promise to address a ... therapies, which focus on the host. This is where a therapy that addresses the microbiome holds much promise ... Investors Collaborate Therapies Leading-edge therapies that leverage the microbiome promise to address a ... therapies, which focus on the host. This is where a therapy that addresses the microbiome holds much promise ...
Blutspende SRK Zürich
https://www.blutspendezuerich.ch/
8952 Schlieren, Rütistrasse 19
+41 58 272 52 52
info@zhbsd.ch
The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).
Blutspende SRK Zürich
Rütistrasse 19
8952 Schlieren
11 Ergebnisse für "promise" unter Blutspende SRK Zürich
... diagnostics. Leveraging the power of long-read sequencing, it shows considerable promise in accurately ... group genes. This method holds promise for improving patient outcomes, particularly for those requiring ... diagnostics. Leveraging the power of long-read sequencing, it shows considerable promise in accurately ... group genes. This method holds promise for improving patient outcomes, particularly for those requiring ...
... shows considerable promise in accurately identifying complex structural variants (SVs) in the RH and MNS ... promise for improving patient outcomes, particularly for those requiring chronic transfusions. ... shows considerable promise in accurately identifying complex structural variants (SVs) in the RH and MNS ... promise for improving patient outcomes, particularly for those requiring chronic transfusions. ...
